In this week’s #Arizona #Bioscience News, OncoMyx, an Arizona State University spinout, receives $50M in funding to advance its #myxoma #immunotherapy into #clinicaltrials. Plus Arizona Commerce Authority Arizona Innovation Challenge winners and more. bit.ly/3ILTpE6

We are proud to partner with OncoMyx on this next stage of their growth. Congratulations to the OncoMyx team! cc: Robert Mittendorff, MD, MBA, Widya Mulyasasmita, Megan Kotrappa

Thank you!

Want to learn more about the #myxomavirus and its #cancer-combatting potential? Here’s a summary of a review written by our cofounder Grant McFadden news-medical.net/news/20211130/… #precisionmedicine #oncology #cancers #immunotherapies #oncolytic #oncolyticvirus #myxoma Biodesign Institute at Arizona State University

New year, new #job? We are looking for a CBO that is passionate about fighting #cancer and experienced in #businessdevelopment. Help our team advance a new #immunotherapy platform: oncomyx.com/careers/ #careers #biotech #westcoast #lifesciences #cancer #nowhiring #jobopening

#WorldCancerDay is today, and we are helping to raise awareness of some common #cancer signs and symptoms. While symptoms may vary, early detection can be helpful in #cancerprevention. Learn more at: worldcancerday.org/what-cancer

#Phoenix is hot and so is the science. At the heart of #DTPHX, scientific innovation is heating up at @Biomed_PHX. We're proud to be part of this community that supports our development of #cancer-fighting therapies. dtphx.org/2022/02/01/inn… #AZ #biotech Downtown Phoenix Arizona State University

For Women in Science Day, we asked our Chief Scientific Officer, Dr. Leslie Sharp for a piece of career advice. She highlighted the different types of mentors that #womeninscience need. Here’s a good article on the topic. #womeninSTEM #EqualityInScience hrdailyadvisor.blr.com/2018/11/14/the…

.Technology Networks spoke with our cofounder Grant McFadden about harnessing the #oncolytic potential of the #myxomavirus to induce an anti-#tumor response to combat #cancer. Read the article here: technologynetworks.com/cancer-researc… #myxoma #immunotherapy #cancers #tumors

Today we announce the appointment of Robert Williamson as Chief Business and Chief Financial Officer. Mr. Williamson has > 20 years of experience in building, financing, and leading biotech companies through critical phases of growth. oncomyx.com/oncomyx-appoin… #biotech #phoenix

OncoMyx Presents New Data at #AACR22 Demonstrating Multi-Armed #Myxoma Virus Coordinates Tumor-Killing by Activating Innate and Adaptive Immune Response oncomyx.com/oncomyx-presen… #cancer #cancers #oncology #myxomavirus #oncolyticviruses #immunotherapy #multiplemyeloma #myeloma

May is #NationalCancerResearchMonth. An analysis in 2021 found that ~7% of patients respond to genome-targeted therapy. We are committed to developing new #oncolytic #immunotherapies and targeted treatments to help more #cancer patients. #NCRM22 #oncology #myxoma #myxomavirus

Recently, our cofounder Grant McFadden spoke with Arizona State University Research on the #cancer-fighting potential of #oncolyticviruses to improve human health. Thank you #ASUResearch for fostering a #community of scientific #innovation in #Phoenix. research.asu.edu/about-us/year-… #AZ #biotech #myxoma

In a recent article, our cofounder Grant McFadden spoke with Nature Portfolio on the next generation of #oncolyticviruses and #cancer-fighting #immunotherapies. Read more: nature.com/articles/s4385… #myxoma #myxomavirus #cancers #oncolytic #immunotherapy #oncology

Thank you, InBusinessPhx for speaking with our CEO on the scientific innovation happening right here in #Phoenix. We are proud to be part of the #AZ #biomedical community as we develop #cancer-fighting therapies. inbusinessphx.com/economy-trends… #biotech #oncology #cancers #myxoma

In our last post for #NationalCancerResearchMonth we are sharing an interview our cofounder Grant McFadden did with Pharma’s Almanac about how viruses can be used for good and how the #myxoma has natural #cancer killing abilities. pharmasalmanac.com/r250-trip/day-… #NCRM #cancerresearch

ICYMI Oncotarget covered the potential of our multi-armed #myxomavirus as a new #immunotherapy approach to treat #multiplemyeloma. Read or listen: oncotarget.org/2022/03/17/tre… #cancer #cancers #oncology #myxoma #oncolyticviruses #oncolytic #immunotherapies #myeloma #bloodcancers

We will be presenting at #BIO2022. Join our CEO Steven Potts next Wednesday, June 15 to learn about our multi-armed #myxomavirus and its #cancer-combatting potential. To register: bio.org/events/bio-int… #cancers #oncology #oncolyticviruses #immunotherapy #Phoenix #PHX #biotech

Don't forget we are presenting at #BIO2022 this Wednesday! Learn about our multi-armed #myxomavirus as a potential #cancer #immunotherapy. More info: bio.org/events/bio-int… #cancers #oncology #oncolyticvirus #Phoenix #PHX #biotech

Join our CEO Steven Potts today at 4:15pm PT at #BIO2022 as he presents the latest on our multi-armed #myxomavirus and its #oncolytic #immunotherapy potential. More info: bio.org/events/bio-int… #myxomavirus #cancer #cancers #oncology #Phoenix #PHX #biotech